Skip to main content
Funded Studies

Clemens Scherzer, MD

Associate Professor of Neurology at Harvard Medical School

Director of the APDA Center for Advanced Parkinson’s Disease Research at Brigham and Women’s Hospital

Location: Boston, MA United States

Dr. Clemens Scherzer is a physician-scientist and the founding director of the APDA Center for Advanced Parkinson’s Disease Research of Brigham & Women’s Hospital and Harvard Medical School. He is director of the Precision Neurology Program of Brigham & Women’s Hospital and Associate Professor of Neurology at Harvard Medical School.

Dr. Scherzer uses genomes big data, and deep cohorts to develop predictive and proactive health care for Parkinson’s and neurologic diseases. To predict how the human genome codes brain cells in health and disease, he is establishing a Brain Cell Encyclopedia of transcribed elements in human brains. His interdisciplinary lab includes computer scientists, biologists and clinicians, and its goal is to match drugs and tests to a patient based on disease biology.

Dr. Scherzer has received the Dr. Paul Beeson and the George C. Cotzias Memorial Awards. He was nominated to the Scientific Advisory Board of the American Parkinson Disease Foundation, the Parkinson Research Vision Setting Panel of the U.S. Department of Defense, the editorial boards of Neurogenetics and Biomarkers in Medicine, and he co- chaired the Technical Working Group of the Accelerating Medicine Partnership Parkinson’s Disease (AMP PD) program.


Associated Grants

  • Study in Norwegian Population to Identify Therapies with Repurposing Potential for Parkinson’s Disease

    2019


  • Charting a Path to Success for Clinical Trials in Patients with Inherited, GBA-linked Parkinson's Disease: PPMI Supplement

    2018


  • Searching for the Cause of Parkinson’s Disease in People with GBA Mutations

    2017


  • GBA Meta-analysis Initiative: Charting a Path to Success for Clinical Trials in Patients with GBA-PD

    2016


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.